Circulating Natural Autoantibodies to HER2-Derived Peptides Performed Antitumor Effects on Oral Squamous Cell Carcinoma

Código QR

Circulating Natural Autoantibodies to HER2-Derived Peptides Performed Antitumor Effects on Oral Squamous Cell Carcinoma

Natural autoantibodies play a crucial role in destruction of malignant tumors due to immune surveillance function. Epidermal growth factor receptor 2 (HER2) has been found to be highly expressed in a variety of epithelial tumors including oral squamous cell carcinoma (OSCC). The present study was th...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xiu Liu, Ziyi He, Yi Qu, Qingyong Meng, Lizheng Qin, Ying Hu
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	circulating natural autoantibodies HER2 oral squamous cell carcinoma trastuzumab intravenous immunoglobulin Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/90c221b150d64320b710f41e3523a896
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Squamous cell carcinoma of the soft palate associated with autoantibodies to desmoglein 1 and 3
por: Yoshifumi Maumi, et al.
Publicado: (2013)

Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
por: Salkeni MA, et al.
Publicado: (2021)

Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review
por: Linehan AS, et al.
Publicado: (2021)

Successful Prevention of Fetal Autoimmune-Mediated Heart Block by Combined Therapies With Hydroxychloroquine and Intravenous Immunoglobulin: A Case Report
por: Li Zhao, et al.
Publicado: (2021)

Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
por: Jagosky M, et al.
Publicado: (2021)

Necrolisis epidérmica tóxica. Terapia en UCI con inmunoglobulinas intravenosas en un caso
por: Andresen H,Max, et al.
Publicado: (2000)

Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells
por: Rodríguez-Serrano F, et al.
Publicado: (2016)

Acantholytic Squamous Cell Carcinoma
por: Sandy Maganito, et al.
Publicado: (2021)

Características clínicas y pronóstico de pacientes con cáncer de mama HER2 positivo avanzado, en la era antes y después de terapias anti-HER2
por: SÁNCHEZ,CESAR, et al.
Publicado: (2018)

Encefalopatía aguda en un paciente tratado con inmunoglobulina endovenosa por un síndrome de Guillain-Barré
por: Soto V,Álvaro, et al.
Publicado: (2011)

Características epidemiológicas del síndrome de Guillain-Barré en población chilena: estudio hospitalario en un período de 7 años
por: Cea,Gabriel, et al.
Publicado: (2015)

2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab
por: Nathalie I. Bouwer, et al.
Publicado: (2021)

The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study
por: Andrea Villasco, et al.
Publicado: (2021)

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
por: Rodallec A, et al.
Publicado: (2018)

Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review
por: Shi Y, et al.
Publicado: (2021)

Multimodal Imaging Technology Effectively Monitors HER2 Expression in Tumors Using Trastuzumab-Coupled Organic Nanoparticles in Patient-Derived Xenograft Mice Models
por: Li Wen, et al.
Publicado: (2021)

Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report
por: Kato Y, et al.
Publicado: (2021)

Cien años de la enfermedad de Alzheimer: La inmunoterapia ¿una esperanza?
por: Behrens P,María Isabel, et al.
Publicado: (2007)

Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes
por: Shi M, et al.
Publicado: (2018)

INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
por: V. A. Lazanovich, et al.
Publicado: (2014)

ASSESSMENTS OF AUTOANTIBODY AND CYTOKINE CONTENTS IN TEENAGERS OF INDUSTRIAL CENTERS SCREENING EXAMINATION
por: L. B. Masnaviyeva, et al.
Publicado: (2012)

Data provision of PIK3CA gene diversity and recombinant plasmids preparation for control DNA in developing the trastuzumab predictive response diagnostic kit
por: DESRIANI DESRIANI, et al.
Publicado: (2016)

IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
por: Alena Gribko, et al.
Publicado: (2021)

4NQO Carcinogenesis: A Model of Oral Squamous Cell Carcinoma
por: Rivera Martínez,César Andrés
Publicado: (2012)

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
por: S. A. Sel'kov, et al.
Publicado: (2014)

Intravenous Immunoglobulin and its Complications
por: I Mohammadzadeh
Publicado: (2011)

Oral and Oropharyngeal Squamous Cell Carcinoma in Our Population: The Clinic-Pathological and Morphological Description of 153 Cases
por: Agarwal,A. K, et al.
Publicado: (2011)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
por: Pei-Hung Chang, et al.
Publicado: (2021)

Assessment of Tumor Associated Tissue Eosinophilia (TATE) in Oral Squamous Cell Carcinoma Using Carbol Chromotrope Stain
por: Peter,Celestina Dawn, et al.
Publicado: (2015)

APPLICATION OF DIFFERENT LABORATORY METHODS FOR ANTINUCLEAR AUTOANTIBODIES INVESTIGATION IN PATIENTS WITH AUTOIMMUNE CONNECTIVE TISSUE DISEASES
por: I. A. Pashnina, et al.
Publicado: (2012)

Oral Squamous Cell Carcinoma Associated with Arsenic Exposure: A Case Series from Argentina
por: Leonardi,Nicolás, et al.
Publicado: (2020)

Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature
por: Belal Firwana, et al.
Publicado: (2012)

EFFECTS OF IVIG TREATMENT UPON LOCAL AND GENERAL IMMUNITY STATE IN THE PATIENTS WITH ACUTE EPIGLOTTITIS
por: A. V. Savchenko, et al.
Publicado: (2014)

Immunoexpression of p53 in Oral Squamous Cell Carcinoma and Oral Dysplastic Lesions in Patients with the Habit of Reverse Smoke
por: Álvarez Martínez,Efraín, et al.
Publicado: (2013)

p53 Immunoexpression in Oral Squamous Cell Carcinomas from Different Anatomical Sites: A Comparative Study
por: Sá,Cláudia T., et al.
Publicado: (2006)

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers
por: Hye Ryeon Kim, et al.
Publicado: (2021)

Content of autoantibodies in teenagers with chronic pathology of upper respiratory tract who live in an industrial center
por: L. B. Masnavieva, et al.
Publicado: (2013)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
por: E. A. Golikova, et al.
Publicado: (2012)

Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma
por: Kustic,Domagoj, et al.
Publicado: (2019)

Myositis Specific Autoantibodies: A Clinical Perspective
por: Alenzi FM
Publicado: (2020)